A basic understanding of how imaging nanoparticles are removed from the normal
organs/tissues but retained in the tumors is important for their future clinical applications in …

While inorganic nanoparticles (NPs) with tunable and diverse material properties open up
unprecedented opportunities for novel biomedical technologies, translating these NPs into …

Glutathione-coated luminescent gold nanoparticles (GS-AuNPs) with diameters of∼ 2.5 nm
behave like small dye molecules (IRDye 800CW) in physiological stability and renal …

The application of traditional chemotherapy drugs for lung cancer has obvious limitations,
such as toxic side effects, uncontrolled drug-release, poor bioavailability, and drug …

Positron Emission Tomography (PET) is a nuclear medicine imaging technique that is widely
used in early detection and treatment follow up of many diseases, including cancer. This …

Contrast agents used in clinics often exhibit the following pharmacokinetics: rapid diffusion
(short distribution half-life t1/2α), relatively long blood circulation time (long elimination half …

In the past decade, ultrasmall luminescent metal nanoparticles (ULMNPs, d< 3 nm) have
achieved rapid progress in addressing many challenges in the healthcare field because of …

In recent years, cardiovascular immuno-imaging by positron emission tomography (PET)
has undergone tremendous progress in preclinical settings. Clinically, two approved PET …

Nanomaterials are now being used in a wide variety of biomedical applications. Medical and
health-related issues, however, have raised major concerns, in view of the potential risks of …

The nanoprobes for identification of cancer metastases in the mononuclear phagocyte
system (MPS) organs are of significant importance but are limited due to the long-standing …